Perspectives on medical 3D printing at the point-of-care from the new European 3D Printing Special Interest Group

Giovanni Biglino; Carina Hopfner; Joakim Lindhardt; Francesco Moscato; Josep Munuera; Gunpreet Oberoi; Alessandro Tel; Arnau Valls Esteve

doi:10.1186/s41205-022-00167-3

Perspectives on medical 3D printing at the point-of-care from the new European 3D Printing Special Interest Group

3D Print Med. 2023 May 5;9(1):14. doi: 10.1186/s41205-022-00167-3.

Authors

Giovanni Biglino^{1

2}, Carina Hopfner³, Joakim Lindhardt⁴, Francesco Moscato^{5

6

7}, Josep Munuera^{8

9}, Gunpreet Oberoi^{5

10}, Alessandro Tel¹¹, Arnau Valls Esteve^{8

12

13}

Affiliations

¹ Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS2 8HW, UK. g.biglino@bristol.ac.uk.
² National Heart and Lung Institute, Imperial College London, London, UK. g.biglino@bristol.ac.uk.
³ Department of Pediatric Cardiology & Pediatric Intensive Care Medicine, LMU Klinikum, Munich, Germany.
⁴ 3D Printing Center, Aarhus Universitetshospital, Aarhus, Denmark.
⁵ Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
⁶ Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
⁷ Austrian Cluster for Tissue Regeneration, Vienna, Austria.
⁸ 3D Unit (3D4H), Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
⁹ Department of Diagnostic Imaging, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
¹⁰ Austrian Center for Medical Innovation and Technology in Vienna (ACMIT Gmbh), Wiener Neustadt, Austria.
¹¹ University Hospital of Udine, Head & Neck and Neuroscience Department, Clinic of Maxillofacial Surgery, Udine, Italy.
¹² Innovation in Health Technologies, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
¹³ Departament de Medicina i Recerca Translacional, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.

Abstract

This editorial presents the vision for the newly formed (2022) European 3D Special Interest Group (EU3DSIG) in the landscape of medical 3D printing. There are four areas of work identified by the EU3DSIG in the current landscape, namely: 1) creating and fostering communication channels among researches, clinicians and industry, 2) generating awareness of hospitals point-of-care 3D technologies; 3) knowledge sharing and education; 4) regulation, registry and reimbursement models.